Intracellular Delivery of Mitomycin C with Targeted Polysaccharide Conjugates Against Multidrug Resistance

被引:13
作者
Cao, Yu [1 ,2 ]
Chen, Didi [1 ]
Zhao, Peiguang [1 ]
Liu, Lina [1 ]
Huang, Xueying [1 ]
Qi, Chao [2 ]
Liu, Yanli [2 ]
He, Hongxuan [3 ]
Wang, Qian [1 ]
Liu, Yang [1 ]
Chen, Sha [1 ]
机构
[1] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Peoples R China
[2] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China
[3] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing 100101, Peoples R China
关键词
Intracellular drug delivery; Polymeric conjugates; Hepatoma-targeting; Drug resistance; HEPATOCYTES IN-VIVO; MACROMOLECULAR PRODRUGS; DRUG-RESISTANCE; NANOPARTICLES; EFFICIENCY; COMPLEXES; POLYMERS; CHITOSAN; THERAPY; SYSTEMS;
D O I
10.1007/s10439-011-0333-2
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Intracellular targeted conjugates of xyloglucan and mitomycin C (MMC) were synthesized with a lysosomally degradable peptide spacer and galactosamine, a terminal moiety that can be used to target polymeric conjugates to hepatoma. The content of the MMC was about 3.5% (mol) in this conjugate. In an in vitro cytotoxicity experiment, the targeted prodrugs have higher cytotoxicity than free MMC against the drug resistant HepG2 cells. In a human tumor xenograft nude mouse model, the targeted prodrugs generated higher therapeutic effect than non-targeted prodrugs or free MMC. Together, these results suggest that targeted prodrugs, which have improved transfer efficiency and hepatocyte specificity, may be useful for the reversion of drug resistant HepG2 cells.
引用
收藏
页码:2456 / 2465
页数:10
相关论文
共 22 条
[1]   Polymers and nanoparticles: Intelligent tools for intracellular targeting? [J].
Breunig, M. ;
Bauer, S. ;
Goefferich, A. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (01) :112-128
[2]   Drug delivery strategies using polysaccharidic gels [J].
Coviello, Tommasina ;
Matricardi, Pietro ;
Alhaique, Franco .
EXPERT OPINION ON DRUG DELIVERY, 2006, 3 (03) :395-404
[3]   SYNTHESIS AND EVALUATION OF MACROMOLECULAR PRODRUGS OF MITOMYCIN-C [J].
DEMARRE, A ;
SOYEZ, H ;
SCHACHT, E ;
SHOAIBI, MA ;
SEYMOUR, LW ;
RIHOVA, B .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :87-97
[4]   Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo [J].
Dong, Lei ;
Gao, Shuying ;
Diao, Huajia ;
Chen, Jiangning ;
Zhang, Junfeng .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2008, 84A (03) :777-784
[5]   TARGETING OF N-(2-HYDROXYPROPYL)METHACRYLAMIDE CO-POLYMERS TO LIVER BY INCORPORATION OF GALACTOSE RESIDUES [J].
DUNCAN, R ;
KOPECEK, J ;
REJMANOVA, P ;
LLOYD, JB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 755 (03) :518-521
[6]   Lipid Nanomedicines for Anticancer Drug Therapy [J].
Estella-Hermoso de Mendoza, Ander ;
Campanero, Miguel A. ;
Mollinedo, Faustino ;
Blanco-Prieto, Maria J. .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (04) :323-343
[7]  
Hoste K, 2004, INT J PHARMACEUT, V277, P119, DOI 10.1016/j.ijpharm.2003.07.016
[8]   Synthesis and biological evaluation of PEG-substituted macromolecular prodrugs of mitomycin C [J].
Hoste, K ;
Schacht, E ;
Rihova, B .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2002, 17 (02) :123-138
[9]   Lipid nanocapsules: A new platform for nanomedicine [J].
Huynh, N. T. ;
Passirani, C. ;
Saulnier, P. ;
Benoit, J. P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (02) :201-209
[10]   Multi-functional nanocarriers to overcome tumor drug resistance [J].
Jabr-Milane, Lara S. ;
van Vlerken, Lilian E. ;
Yadav, Sunita ;
Amiji, Mansoor M. .
CANCER TREATMENT REVIEWS, 2008, 34 (07) :592-602